$2.59
0.01[0.39%]
Last update: 9:13AM Get Real Time Here
BioXcel Therapeutics
(NASDAQ:BTAI)BioXcel Therapeutics Stock (NASDAQ:BTAI), Earnings Estimates, EPS, and Revenue
BioXcel Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS Estimate
$-0.820
Quarterly Revenue Estimate
$500K
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$1.4M
Analyze the earnings history of BioXcel Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/09/2024 | AM | BTAI | Q1 | -$1.84 | -$0.82 | — | — | $206.00K | $500.00K | — | — | Get Alert |
| 03/12/2024 | AM | BTAI | Q4 | -$1.95 | -$0.91 | -$0.76 | 16.48% | $238.00K | $710.00K | $376.00K | -47.04% | Get Alert |
| 11/14/2023 | AM | BTAI | Q3 | -$1.49 | -$1.31 | -$1.58 | -20.61% | $137.00K | $670.00K | $341.00K | -49.10% | Get Alert |
| 08/14/2023 | AM | BTAI | Q2 | -$1.35 | -$1.75 | -$1.83 | -4.57% | $0.00 | $450.00K | $457.00K | 1.56% | Get Alert |
| 05/08/2023 | AM | BTAI | Q1 | -$1.12 | -$1.62 | -$1.84 | -13.58% | $0.00 | $500.00K | $206.00K | -58.80% | Get Alert |
| 03/09/2023 | AM | BTAI | Q4 | -$0.93 | -$1.45 | -$1.95 | -34.48% | $0.00 | $1.25M | $238.00K | -80.96% | Get Alert |
| 11/10/2022 | AM | BTAI | Q3 | -$0.96 | -$1.35 | -$1.49 | -10.37% | $0.00 | $1.09M | $137.00K | -87.43% | Get Alert |
| 08/09/2022 | AM | BTAI | Q2 | -$1.11 | -$1.22 | -$1.35 | -10.66% | $0.00 | — | $0.00 | — | Get Alert |
| 05/09/2022 | AM | BTAI | Q1 | -$1.08 | -$1.15 | -$1.12 | 2.61% | $0.00 | $120.00K | $0.00 | -100.00% | Get Alert |
| 03/10/2022 | AM | BTAI | Q4 | -$0.87 | -$1.10 | -$0.93 | 15.45% | $0.00 | — | $0.00 | — | Get Alert |
| 11/10/2021 | AM | BTAI | Q3 | -$1.07 | -$1.05 | -$0.96 | 8.57% | $0.00 | — | $0.00 | — | Get Alert |
| 08/10/2021 | AM | BTAI | Q2 | -$1.06 | -$1.08 | -$1.11 | -2.78% | $0.00 | — | $0.00 | — | Get Alert |
| 05/10/2021 | AM | BTAI | Q1 | -$0.79 | -$0.94 | -$1.08 | -14.89% | $0.00 | — | $0.00 | — | Get Alert |
| 03/11/2021 | AM | BTAI | Q4 | -$0.45 | -$0.96 | -$0.87 | 9.38% | $0.00 | — | $0.00 | — | Get Alert |
| 11/12/2020 | AM | BTAI | Q3 | -$0.57 | -$0.80 | -$1.07 | -33.75% | $0.00 | — | $0.00 | — | Get Alert |
| 08/14/2020 | AM | BTAI | Q2 | -$0.54 | -$0.75 | -$1.06 | -41.33% | $0.00 | — | $0.00 | — | Get Alert |
| 05/12/2020 | AM | BTAI | Q1 | -$0.46 | -$0.59 | -$0.79 | -33.90% | $0.00 | — | $0.00 | — | Get Alert |
| 03/09/2020 | AM | BTAI | Q4 | -$0.46 | -$0.59 | -$0.45 | 23.73% | $0.00 | — | $0.00 | — | Get Alert |
| 11/14/2019 | AM | BTAI | Q3 | -$0.31 | -$0.65 | -$0.57 | 12.31% | $0.00 | — | $0.00 | — | Get Alert |
FAQ
When is BioXcel Therapeutics (NASDAQ:BTAI) reporting earnings?
BioXcel Therapeutics (BTAI) is scheduled to report earnings on May 9, 2024. The last reported earnings were for reported on March 12, 2024 for Q4.
What were the latest earnings per share (EPS) for BioXcel Therapeutics (NASDAQ:BTAI)?
The Actual EPS was $-0.76, which beat the estimate of $-0.91.
What were BioXcel Therapeutics’s (NASDAQ:BTAI) revenues?
The Actual Revenue was $376K, which missed the estimate of $710K.
Browse earnings estimates, EPS, and revenue on all stocks.